The exit from unprofitable markets and brands as well as the impact of restructuring led to an organic sales decline ranging between 2% and 10% across all of the division’s health themes.
|
Consumer Health | Core brands | ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bion® |
|
Cebion |
|
|
| ||||
|
|
femibion® |
| ||
|
| ||||
|
|
Kytta® |
|
Nasivin® |
|
|
| ||||
|
|
Seven Seas® |
| ||
|
| ||||
|
|
Sangobion® |
| ||
|
| ||||
|
|
Sedalmerck® |
| ||
|
|
|
|
|
|
back
